Trial Search Results
Prevention of Persistent Opioid Use in Mothers
Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.
Stanford is currently accepting patients for this trial.
- Drug: Gabapentin
- Drug: Placebo
- Delivery within 5 days, able to provide informed consent, English speaker
- Opiate use disorder
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study